Does HRCT Pattern Influence the Effect of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases?

被引：0
|
作者：
Brown, K. K. [1 ]
Walsh, S. L. F. [2 ]
Devaraj, A. [3 ]
Song, J. [4 ]
Wuyts, W. A. [5 ]
Valenzuela, C. [6 ]
Goeldner, R. [7 ]
Stowasser, S. [8 ]
Schlenker-Herceg, R. [9 ]
Wells, A. U. [2 ,10 ]
机构：
[1] Natl Jewish Hlth, Pulm Crit Care & Sleep Med, Denver, CO USA
[2] Imperial Coll, Natl Heart & Lung Inst, London, England
[3] Royal Brompton & Harefield NHS Fdn Trust, Dept Radiol, London, England
[4] Univ Ulsan, Asan Med Ctr, Pulm & Crit Care Med, Coll Med, Seoul, South Korea
[5] Univ Hosp Leuven, Dept Resp Med, Unit Interstitial Lung Dis, Leuven, Belgium
[6] Hosp Univ La Princesa, Madrid, Spain
[7] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
[8] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[9] Boehringer Ingelheim Pharmaceut Inc, 90 E Ridge POB 368, Ridgefield, CT 06877 USA
[10] Royal Brompton & Harefield NHS Fdn, Natl Inst Hlth Res Resp Biomed Res Unit, London, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1507
引用
收藏
页数：2
相关论文
共 50 条
  • [21] THE INBUILD TRIAL OF NINTEDANIB IN PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES: SUBGROUP OF ASIAN PATIENTS
    Inoue, Yoshikazu
    Wells, Athol U.
    Song, Jin Woo
    Xu, Zuojun
    Kitamura, Hideya
    Suda, Takafumi
    Okamoto, Masaki
    Schlenker-Herceg, Rozsa
    Kolb, Martin
    Brown, Kevin K.
    Quaresma, Manuel
    Kolb, Martin
    Brown, Kevin K.
    RESPIROLOGY, 2019, 24 : 87 - 88
  • [22] Nintedanib in Asian patients with progressive fibrosing interstitial lung diseases: Results from the INBUILD trial
    Inoue, Yoshikazu
    Wells, Athol U.
    Song, Jin Woo
    Xu, Zuojun
    Kitamura, Hideya
    Suda, Takafumi
    Okamoto, Masaki
    Mueller, Heiko
    Coeck, Carl
    Rohr, Klaus B.
    Kolb, Martin
    Brown, Kevin K.
    RESPIROLOGY, 2023, 28 (05) : 465 - 474
  • [23] Effects of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) by Composite Physiologic Index (CPI)
    Nambiar, A. M.
    Molina-Molina, M.
    Padilla, M.
    Song, J.
    Mueller, H.
    Stowasser, S.
    Rohr, K. B.
    Wells, A. U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [24] Effects of Nintedanib on Circulating Biomarkers in Subjects with Progressive Fibrosing Interstitial Lung Diseases (ILDs)
    Maher, T. M.
    Jenkins, R. G.
    Bonella, F.
    Assassi, S.
    Diefenbach, C.
    Ittrich, C.
    Rohr, K. B.
    Kolb, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [25] Nintedanib in children and adolescents with fibrosing interstitial lung diseases
    Deterding, Robin
    Young, Lisa R.
    DeBoer, Emily M.
    Warburton, David
    Cunningham, Steven
    Schwerk, Nicolaus
    Flaherty, Kevin R.
    Brown, Kevin K.
    Dumistracel, Mihaela
    Erhardt, Elvira
    Bertulis, Julia
    Gahlemann, Martina
    Stowasser, Susanne
    Griese, Matthias
    EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (02)
  • [26] Effect of Nintedanib on Decline in Forced Vital Capacity (FVC) in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) by GAP Stage
    Ryerson, C. J.
    Chaudhuri, N.
    Perez, E. R. Fernandez
    Kim, Y.
    Silva, R. S.
    Wuyts, W. A.
    Mueller, H.
    Rohr, K. B.
    Kolb, M. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [27] Effects of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) Taking Anti-Acid Therapy
    Kreuter, M.
    Glazer, C.
    Kitamura, H.
    Koschel, D.
    Moua, T.
    Mueller, H.
    Stowasser, S.
    Rohr, K. B.
    Brown, K. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [28] EFFECTS OF NINTEDANIB ON CIRCULATING BIOMARKERS IN PATIENTS WITH PROGRESSIVE FIBROSING AUTOIMMUNE DISEASE-RELATED INTERSTITIAL LUNG DISEASES
    Maher, T.
    Bonella, F.
    Assassi, S.
    Noth, I.
    Diefenbach, C.
    Ittrich, C.
    Rohr, K.
    Kolb, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 722 - 722
  • [29] Effect of Nintedanib on Decline in Forced Vital Capacity (FVC) in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) by Time Since Diagnosis
    Strek, M. E.
    Hallowell, R. W.
    Kus, J.
    Nunes, H.
    Suda, T.
    Tomassetti, S.
    Mueller, H.
    Rohr, K. B.
    Flaherty, K. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [30] Effect of nintedanib on decline in forced vital capacity (FVC) in patients with progressive fibrosing interstitial lung diseases (ILDs) by time since diagnosis
    Skowasch, D.
    Strek, M.
    Hallowell, W. R.
    Kus, J.
    Nunes, H.
    Suda, T.
    Tomassetti, S.
    Mueller, H.
    Rohr, B. K.
    Flaherty, R. K.
    PNEUMOLOGIE, 2022, 76 : S22 - S22
12345